Drugs that contain Deferasirox

1. Drug name - JADENU

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9283209 NOVARTIS PHARMS CORP Oral formulations of deferasirox
Nov, 2034

(12 years from now)

CN105025886B NOVARTIS PHARMS CORP Oral Preparation Of Deferasirox (Deferasirox)
Mar, 2034

(11 years from now)

CN105025886A NOVARTIS PHARMS CORP Oral Preparation Of Deferasirox (Deferasirox)
Mar, 2034

(11 years from now)

EP3124018A1 NOVARTIS PHARMS CORP Oral Formulations Of Deferasirox
Mar, 2034

(11 years from now)

EP2964202A1 NOVARTIS PHARMS CORP Oral Formulations Of Deferasirox
Mar, 2034

(11 years from now)

EP2964202B1 NOVARTIS PHARMS CORP Oral Formulations Of Deferasirox
Mar, 2034

(11 years from now)

EP3124018B1 NOVARTIS PHARMS CORP Oral Formulations Of Deferasirox
Mar, 2034

(11 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
90MG TABLET;ORAL Prescription
180MG TABLET;ORAL Prescription
360MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.